Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195233 | SCV000248380 | uncertain significance | not specified | 2015-04-23 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000714602 | SCV000845312 | uncertain significance | Lowe syndrome | 2018-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000714602 | SCV002398801 | benign | Lowe syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020329 | SCV002626398 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001701636 | SCV001931315 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001701636 | SCV001962875 | likely benign | not provided | no assertion criteria provided | clinical testing |